
Mantis Biotech
We are building a unified biomedical device testing and regulatory platform that connects every stage of product development from CAD design through simulation, bench testing, and verification to FDA Q-Submissions.
Mantis Biotech raised $6.3M in a Seed round announced January 29, 2026, according to linkedin.com. Investors in that round: Decibel Partners.
Raise history
- First seen by Recent Fundingvia startups.gallery
- Seed · $6.3M
DDecibel Partners (lead)
Source: linkedin.com (startups.gallery listing)
Investors
Related other companies
QQuartermaster$140M · Sep 28, 2026
SSnorkel AI$350M · Sep 23, 2026
EEnveda$311M · Sep 23, 2026
HHeidi Health$100M · Sep 22, 2026FFirecrawl$75M · Sep 22, 2026
CCorridor$25M · Sep 21, 2026- JJack & Jill$40M · Sep 19, 2026
- MMithr Inc.$20M · Sep 19, 2026
Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/mantis-biotech.